Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Moxifloxacin (0.5% w/v) + Prednisolone (1% w/v)
Therapeutic Category
Ophthalmology, Antibiotic
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
5ml
Price
₹149/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Moxolunic PD Eye Drop combines Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic, with Prednisolone 1% w/v, a potent corticosteroid, to provide dual action in the treatment of ocular infections with associated inflammation. Moxifloxacin works by inhibiting bacterial DNA replication, while Prednisolone reduces redness, swelling, and irritation.
This formulation is ideal for managing bacterial conjunctivitis, post-operative inflammation, and other eye infections where both antimicrobial and anti-inflammatory therapy is required. Moxolunic PD ensures fast symptom relief, reduces the risk of complications, and promotes quicker healing of ocular tissues.
Possible side effects include ear irritation, a temporary burning sensation, or itching. In rare cases, allergic reactions or worsening of ear conditions may occur. Consult a healthcare provider if any severe reactions develop.
Acute otitis externa (outer ear infection) Otitis media (middle ear infection) Bacterial ear infections with inflammation
Do not use if you have a perforated eardrum or a history of allergic reactions to any of the ingredients. Consult your doctor if pregnant or breastfeeding.
Store at room temperature, away from direct sunlight. Keep the bottle tightly closed and out of reach of children.
Composition : Moxifloxacin (5% w/v) + Betamethasone (0.1% w/v)
Composition : Moxifloxacin (0.5% w/v) + Difluprednate (0.05% w/v)
Composition : Moxifloxacin (0.5% w/v) + Dexamethasone (0.1% w/v)
Composition : Ofloxacin (0.3% w/v) Eye Ear Drops
Composition : Moxifloxacin (0.5% w/v)
Composition : Ofloxacin (0.3% w/v) + Ketorolac (0.5% w/v)
Composition : Amoxycillin (80mg) + Clavulanic Acid (11.4mg) Drops
Composition : Cefixime (25mg) Drop
Composition : Cefpodoxime Proxetil (25mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Moxifloxacin 0.5% w/v + Prednisolone 1% w/v Ear Drops have strong demand in the ENT, anti-infective, and specialty healthcare segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on ear infection and inflammation management portfolios.
Medical distributors and agencies can benefit from consistent demand for ear infection and inflammatory condition management under medical supervision. Moxifloxacin 0.5% w/v is a broad-spectrum fluoroquinolone antibiotic used to treat susceptible bacterial infections Prednisolone 1% w/v is a corticosteroid that helps reduce inflammation, swelling, redness, and discomfort Commonly prescribed for bacterial otitis externa, inflamed ear infections, post-infective ear conditions, and ENT-related inflammatory disorders as advised by healthcare professionals The combination helps manage both infection and inflammation effectively Ear drop formulation ensures targeted delivery directly to the affected site Widely prescribed by ENT specialists, physicians, and general practitioners This strengthens a comprehensive ENT and anti-infective portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Moxifloxacin 0.5% w/v + Prednisolone 1% w/v Ear Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong ENT prescription demand, repeat orders, reliable supply chain support, and attractive margins in the ear care and anti-infective segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.